S-1/A: Origin Investment Corp I Files Amended S-1 for $60 Million Asia-Focused SPAC IPO

Origin Investment Corp I, a blank check company, filed an amended S-1 registration statement for its initial public offering of 6 million units at $10.00 each, aiming to acquire businesses primarily in Asia's financial services, technology, biotechnology, advanced materials, and clean energy sectors.

Summary

• Origin Investment Corp I is a Cayman Islands exempted blank check company formed to effect a business combination with one or more businesses.
• The company plans an initial public offering of 6,000,000 units at $10.00 per unit, with each unit consisting of one ordinary share and one-half of one redeemable warrant.
• The underwriters have a 45-day option to purchase up to an additional 900,000 units to cover over-allotments.
• The sponsor, Origin Equity LLC, will purchase 355,000 private units at $10.00 per unit for an aggregate of $3,550,000 in a concurrent private placement.
• A total of $60,600,000 (or $69,690,000 if the over-allotment option is fully exercised) from the offering and private placement will be deposited into a trust account.
• The company has 24 months from the closing of the offering to complete its initial business combination, with potential for extensions requiring shareholder approval.
• Target businesses will primarily be private companies in Asia, excluding those with China operations consolidated through a variable interest entity (VIE) structure.
• Key target industries include Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy.
• Public shareholders will have the opportunity to redeem their shares for cash at a per-share price equal to the pro-rata amount in the trust account upon completion of a business combination or liquidation if no combination is achieved.
• The sponsor acquired 1,725,000 founder shares for a nominal price of $25,000, or approximately $0.014 per share, which will represent 20% of the outstanding shares post-offering (assuming forfeiture of 225,000 shares if over-allotment is not exercised).
• The company's net tangible book value as of December 31, 2024, was a deficit of $253,163, or approximately $(0.15) per ordinary share.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the inherent high risks of a blank check company, particularly the significant dilution for public shareholders, the potential for conflicts of interest due to the sponsor's low-cost founder shares, and the lack of an operating history. While the experienced management team and focus on growing Asian sectors are positive, the fundamental uncertainties and structural disadvantages for public investors weigh heavily on the overall sentiment.

Positives

• The management team and board of directors possess extensive experience in financial services, M&A, and operating companies across multiple jurisdictions, particularly in Asia.
• The company aims to capitalize on the growing Asian emerging market, which is expected to expand by 5.2% in 2024, significantly higher than the 3.2% global growth.
• The current tough IPO market and valuation environment in Asia Pacific (IPO proceeds dropped 33% in 2023) may make de-SPAC transactions an attractive alternative for target businesses, potentially increasing acquisition opportunities.
• Target industries (Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, Clean Energy) are identified as attractive due to transformative growth, technological advancements (e.g., AI, blockchain), and substantial investment.
• The company's structure as a publicly listed entity offers target businesses an alternative to traditional IPOs, potentially providing a more cost-effective and certain path to public markets, greater access to capital, and enhanced management incentives.
• The company has established deal sourcing networks through its management team's contacts in various financial and industry sectors, which is expected to provide high-quality acquisition opportunities.

Negatives

• Public shareholders will incur immediate and material dilution upon the closing of the offering due to the nominal price paid by the sponsor for founder shares (approximately $0.014 per share vs. $10.00 per unit offering price).
• The nominal purchase price paid by the sponsor creates a significant incentive for officers and directors to complete a business combination, even if it is unprofitable for public shareholders, leading to potential conflicts of interest.
• The company is a blank check company with no operating history or revenues, meaning investors have no basis to evaluate its ability to achieve its business objective.
• The ability of public shareholders to redeem shares for cash may make the company's financial condition unattractive to potential target businesses, potentially hindering the completion of a desirable business combination.
• The 24-month deadline to complete a business combination may give potential target businesses leverage in negotiations and limit the time for due diligence.
• The company may be required to seek additional financing (e.g., PIPE transactions, convertible debt) to complete a business combination, which could be significantly dilutive to existing shareholders.
• The company's officers and directors are not required to commit full-time to its affairs and have other business affiliations, leading to potential conflicts of interest in allocating time and presenting business opportunities.
• The company is incorporated under Cayman Islands law, which provides less protection to investors compared to U.S. federal courts, and enforcement of U.S. judgments may be difficult.
• The company faces significant competition from other SPACs, private equity groups, and operating businesses, which could increase acquisition costs or make it difficult to find attractive targets.
• The company may be deemed a passive foreign investment company (PFIC), which could result in adverse U.S. federal income tax consequences for U.S. investors.

Risks

• The company has no operating history and no revenues, providing no basis to evaluate its ability to achieve its business objective.
• Public shareholders may not have an opportunity to vote on the proposed initial business combination, and even if a vote is held, founder share holders' votes may lead to approval despite public shareholder dissent.
• The only opportunity for public shareholders to effect their investment decision regarding a potential business combination may be limited to exercising redemption rights for cash.
• The sponsor controls the appointment of the board of directors until the initial business combination, potentially exerting substantial influence on shareholder votes.
• The ability of public shareholders to redeem shares for cash may make the company's financial condition unattractive to potential business combination targets.
• A large number of redemptions could prevent the company from completing the most desirable business combination or optimizing its capital structure, and may substantially dilute investments.
• The 24-month deadline for completing a business combination may give target businesses leverage and limit due diligence time.
• The sponsor, initial shareholders, directors, officers, and their affiliates may purchase public shares or warrants, which could influence a vote on a proposed business combination and reduce the public float.
• Shareholders may lose redemption rights if they fail to receive notice or comply with procedures for submitting shares.
• Officers and directors allocate time to other businesses, causing conflicts of interest that could negatively impact the ability to complete a business combination.
• Public shareholders will not have rights or interests in funds from the trust account except under limited circumstances, forcing them to sell shares or warrants, potentially at a loss, to liquidate their investment.
• NASDAQ may delist the company's securities, limiting trading ability and subjecting the company to additional restrictions.
• The nominal purchase price paid by the sponsor for founder shares results in significant dilution to the implied value of public shares upon business combination.
• The company is not subject to Rule 419 blank check offering protections, meaning investors will not receive certain benefits or protections.
• Limited resources and significant competition for business combination opportunities may make it difficult to complete an initial business combination, potentially leading to public shareholders receiving only a pro rata portion of trust funds and warrants expiring worthless.
• Insufficient funds outside the trust account could limit the search for a target business, making the company dependent on loans from the sponsor or management.
• Past performance by the management team is not indicative of future performance.
• The company may be a passive foreign investment company (PFIC), resulting in adverse U.S. federal income tax consequences to U.S. investors.
• To mitigate PFIC risk, the company may liquidate trust account investments into cash, potentially reducing interest earned and the redemption amount for public shareholders.
• A U.S. federal excise tax could be imposed on redemptions if the initial business combination involves a U.S. company and the company domesticates.
• Being deemed an investment company under the Investment Company Act could impose burdensome compliance requirements and restrict activities.
• Changes in laws or regulations, or non-compliance, may adversely affect the business and ability to complete a business combination.
• Global geopolitical conditions (Russia-Ukraine conflict, Middle East conflict) and the COVID-19 pandemic may materially adversely affect the search for and consummation of a business combination.
• Reincorporation in another jurisdiction may result in taxes for shareholders or warrant holders and may limit legal rights enforcement.
• An investment in the offering may result in uncertain U.S. federal income tax consequences.
• The initial business combination and subsequent structure may not be tax-efficient, leading to more complex, burdensome, or uncertain tax obligations.
• Adverse developments in the financial services industry could affect the company's business, financial condition, or results of operations.
• The requirement to furnish target business financial statements may limit the ability to complete advantageous business combinations.
• Compliance obligations under the Sarbanes-Oxley Act may make it more difficult and costly to effectuate a business combination.
• Subsequent to a business combination, the company may be required to take write-downs, restructurings, or impairment charges.
• Loss of a target business's key personnel could negatively impact post-combination operations.
• Management may not maintain control of a target business after the initial business combination.
• Limited ability to assess target business management may lead to combining with a company whose management lacks public company experience.
• Seeking complex business combination opportunities requiring significant operational improvements could delay or prevent desired results.
• The company may issue additional ordinary or preference shares to complete a business combination or under an employee incentive plan, diluting shareholder interests.
• Shares may be issued to investors in connection with a business combination at a price less than the prevailing market price.
• The sponsor's right to appoint directors means the company is a controlled company, potentially exempting it from certain corporate governance requirements.
• Resources could be wasted on uncompleted business combinations.
• Business combinations with affiliated entities may raise conflicts of interest.
• The value of founder shares is likely to be substantially higher than their nominal purchase price, even if public shares decline.
• The offering price and size are more arbitrary than for an operating company.
• There is currently no market for the company's securities, and one may not develop.
• Cyber incidents or attacks could result in information theft, data corruption, operational disruption, and/or financial loss.
• Changes in the market for directors and officers liability insurance could make it more difficult and expensive to complete a business combination.
• Recent increases in inflation could make it more difficult to complete a business combination.
• The warrant agreement designates New York courts as the exclusive forum for certain actions, potentially limiting warrant holders' ability to choose a favorable judicial forum.
• A provision in the warrant agreement may make it more difficult to consummate an initial business combination.
• Unexpired warrants may be redeemed prior to exercise at a disadvantageous time, making them worthless.
• Warrants may adversely affect the market price of ordinary shares and make it more difficult to effectuate a business combination.
• Each unit contains only one-half of one warrant, potentially making units worth less than those of other SPACs.
• Warrants may not be exercisable unless underlying ordinary shares are registered or certain exemptions are available.
• Public warrants may only be exercisable on a cashless basis under certain circumstances, resulting in fewer ordinary shares.
• The grant of registration rights to the sponsor and other holders may make it more difficult to complete a business combination and adversely affect the market price of ordinary shares.

Future Outlook

The company intends to focus its search for a target business on private companies in Asia with compelling economics, clear paths to positive operating cash flow, and successful management teams seeking access to U.S. public capital markets. It expects to leverage its management team's experience and network to identify attractive acquisition opportunities in Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy. The company anticipates that targets may view de-SPAC transactions as an attractive alternative to traditional IPOs due to the challenging IPO market in Asia Pacific. The company will have 24 months to complete an initial business combination, with the possibility of extensions.

Management Comments

• Management believes their team is well positioned to identify opportunities offering attractive risk-adjusted returns and that their professional contacts and transaction sources will enable them to pursue a broad range of opportunities.
• Management believes their operating expertise is well suited to complement many potential targets' management teams.
• Management believes that the businesses targeted will benefit from access to the U.S. capital markets, as well as the expertise and network of the management team.
• Management intends to focus on creating shareholder value by leveraging its experience in the management, operation, and financing of businesses to improve efficiency and scale revenue organically and/or through acquisitions.
• Management believes the company's structure will make it an attractive business combination partner to target businesses, offering an alternative to traditional IPOs that is more cost-effective and offers greater certainty of execution.
• Management believes that the funds available outside the trust account will be sufficient to operate for at least 24 months, but cannot assure this estimate is accurate.

Industry Context

The company's focus on Asia aligns with the region's sustained economic expansion, with Asian emerging markets expected to grow 5.2% in 2024, significantly outpacing global growth. However, the Asia Pacific region is currently facing a tough IPO market, with proceeds dropping 33% in 2023, making de-SPAC transactions a potentially attractive alternative for private companies seeking public market access. The targeted industries—Financial Services, Technology, Biotechnology & Pharmaceutical, Advanced Materials, and Clean Energy—are all characterized by transformative growth, technological advancements (e.g., AI, blockchain), and substantial investment, indicating a fertile ground for acquisition opportunities. The clean energy sector, in particular, has seen nearly 50% investment growth from 2019 to 2023, reaching $1.8 trillion, driven by global sustainability initiatives.

Comparison to Industry Standards

• The company's unit structure, containing one-half of one redeemable warrant per unit, is designed to reduce the dilutive effect of warrants compared to other SPACs that issue whole warrants, aiming to make the company a more attractive business combination partner.
• The company's initial listing standards on NASDAQ are expected to be met on a pro forma basis, but continued compliance is not assured, which is a common challenge for SPACs post-IPO and pre-business combination.
• The company's redemption rights for public shareholders (up to 15% per shareholder) are a common feature in SPACs, but the absence of a specified maximum redemption threshold means a business combination could be completed even if a substantial majority of public shareholders disagree.
• The company's ability to amend its memorandum and articles of association with a two-thirds shareholder vote is a lower threshold than some other SPACs, potentially making it easier to alter pre-business combination provisions.
• The company's reliance on the JOBS Act exemptions as an 'emerging growth company' and 'smaller reporting company' means it will have reduced disclosure obligations, which may make financial comparisons with other public companies difficult, a common characteristic among newly public smaller entities.

Management Changes

Corporate Governance

Legal Proceedings

• No material litigation, arbitration, or governmental proceeding is currently pending against the company or any members of its management team in their capacity as such.

Related Party Transactions

• Origin Equity LLC (the sponsor) purchased 1,725,000 founder shares for $25,000 (approximately $0.014 per share) on September 25, 2024.
• The sponsor will transfer 25,000 founder shares to Kuo-Shui (Ringo) Chao, 13,000 to Daniel Alef, and 13,000 to Derek Alef as compensation for their services as directors, provided they remain until business combination closing.
• The sponsor will purchase 355,000 private units at $10.00 per unit for $3,550,000 in a private placement concurrent with the IPO.
• The company will pay the sponsor $25,000 per month for office space, administrative, and support services, ceasing upon business combination completion or liquidation.
• The sponsor, officers, and directors, or their affiliates, will be reimbursed for out-of-pocket expenses incurred in identifying, investigating, and completing a business combination, with no cap or ceiling on reimbursement.
• The sponsor loaned the company up to $500,000 for offering-related and organizational expenses, with $169,877 borrowed as of December 31, 2024, repayable upon IPO closing.
• The sponsor or affiliates may loan up to $1,500,000 for transaction costs related to an initial business combination, convertible into private units at $10.00 per unit at the lender's option.
• The company has entered into a registration rights agreement with the sponsor and other security holders for founder shares, private units, and working capital loan units.

Stakeholder Impact

• **Shareholders (Public)**: Will experience immediate and material dilution due to the low cost of founder shares. Their investment is subject to the risk of the company not completing a business combination within 24 months, potentially leading to liquidation at a pro-rata share of the trust account, and warrants expiring worthless. Redemption rights are available but limited to 15% per shareholder, and may be influenced by sponsor purchases.
• **Shareholders (Sponsor/Initial)**: Stand to make a substantial profit even if the post-combination share price declines, due to their nominal initial investment in founder shares. They have significant control over the company's direction and business combination approval.
• **Employees (Post-Combination)**: The target business's existing management may or may not remain, and the company may seek to recruit additional managers. The ability to attract talented staff is cited as a benefit of being a public company.
• **Creditors**: Claims of creditors may take priority over public shareholders' claims in the event of liquidation, potentially reducing the per-share redemption amount. The sponsor has agreed to indemnify the company against certain third-party claims, but its ability to satisfy these obligations is not assured.
• **Underwriters**: Receive underwriting commissions (1% of gross public proceeds) and 30,000 ThinkEquity units (or up to 34,500 units if over-allotment exercised) as compensation, subject to lock-up and transfer restrictions. They also have a right of first refusal for future financial advisory and capital raising services.

Next Steps

• Complete the initial public offering of 6,000,000 units.
• Deposit proceeds into a trust account, with $10.10 per unit held in trust.
• Identify and select one or more target businesses for an initial business combination within 24 months from the closing of the offering.
• Negotiate and sign a definitive agreement for the initial business combination.
• Seek shareholder approval for the business combination if required by law or stock exchange rules, or conduct a tender offer.
• Complete the initial business combination, potentially seeking additional financing (PIPE or convertible debt) if needed.
• List ordinary shares and warrants separately on NASDAQ after the initial trading period of units.
• File a post-effective amendment or new registration statement covering ordinary shares issuable upon warrant exercise within 15 business days after business combination closing.
• Comply with internal control requirements of the Sarbanes-Oxley Act, beginning with the first Annual Report on Form 10-K for the year ending December 31, 2025.

Key Dates

Keywords

SPAC, Special Purpose Acquisition Company, Blank Check Company, IPO, Initial Public Offering, Merger, Acquisition, Business Combination, Warrants, Ordinary Shares, Founder Shares, Private Placement, Trust Account, Redemption Rights, Dilution, Corporate Governance, Risk Factors, Asia Market, Financial Services, Technology, Biotechnology, Pharmaceutical, Advanced Materials, Clean Energy, SEC Filing, S-1/A, NASDAQ Listing